Optogenerapy partner Emilie Audouard, postdoctoral researcher at the INSERM’s Institute of the Brain and Spine Diseases presented a poster based on Optogenerapy research during the 27th Annual Congress of the European Society of Gene & Cell Therapy, taking place in Barcelona on Oct 22-25.
Auduard presented the poster within the Wednesday 23th session. Titled as “Therapeutic approach for Multiple Sclerosis using a bioelectronic cell implant”, the poster presents the Optogenerapy concept, focusing on the tools to study the biocompatibility of the implants and the validation of the therapeutic efficacy in EAE model mice.
CLICK HERE TO DOWNLOAD THE POSTER
The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in gene therapy, cell therapy, and genetic vaccines by facilitating education, the exchange of information and technology and by serving as a professional adviser to stakeholder communities and regulatory bodies in Europe.